F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Trading Up 0.1% – Should You Buy?

Shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) rose 0.1% during trading on Thursday . The stock traded as high as $40.10 and last traded at $36.4890. Approximately 65,385 shares traded hands during mid-day trading, an increase of 1,091% from the average daily volume of 5,490 shares. The stock had previously closed at $36.45.

F/m Emerald Life Sciences Innovation ETF Stock Performance

The stock’s 50 day moving average is $36.73 and its two-hundred day moving average is $32.90.

Hedge Funds Weigh In On F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC raised its stake in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 11.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 40,740 shares of the company’s stock after acquiring an additional 4,101 shares during the period. Hunter Associates Investment Management LLC owned approximately 1.76% of F/m Emerald Life Sciences Innovation ETF worth $1,005,000 as of its most recent SEC filing.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.